The 1938 law mandating animal testing for new drugs was challenged in 2022 with the FDA Modernization Act 2.0, which allows for alternatives like computer modeling and stem cell research. The FDA is phasing out animal testing for some therapies, aiming to accelerate approval processes and lower costs.
FDA Modernization Act 2.0 allows alternatives to animal testing
FDA is phasing out animal testing for some drugs and therapies
New technologies promise to replace routine animal testing, potentially reducing approval times and costs
Running tests on lab rats, mice and other species is an integral part of biomedical research. Now, some say artificial intelligence and other technologies could soon make the practice obsolete.